Chromition Limited

Chromition’s technology is a digital pathology platform that enables rapid diagnosis of cancer. This project will validate the technology in a clinical setting with the end point of accelerating diagnosis and transforming the way histopathology is conducted within the NHS.

Our high-throughput method enables the recognition of meaningful diagnostic patterns of multiple biomarkers in tissue sections. Specifically, tissue biopsies are stained with fluorescent biomarker conjugates, viewed with commercial multispectral microscopy imaging equipment and analysed using pattern recognition software to identify patterns. The method will give greater diagnostic insight than current methods, in less time and with lower costs.